rs11596653

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032578.4(MYPN):​c.1178T>C​(p.Val393Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0316 in 1,613,918 control chromosomes in the GnomAD database, including 4,645 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 2326 hom., cov: 32)
Exomes 𝑓: 0.024 ( 2319 hom. )

Consequence

MYPN
NM_032578.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: 0.416

Publications

14 publications found
Variant links:
Genes affected
MYPN (HGNC:23246): (myopalladin) Striated muscle in vertebrates comprises large proteins which must be organized properly to contract efficiently. Z-lines in striated muscle are a sign of this organization, representing the ends of actin thin filaments, titin, nebulin or nebulette and accessory proteins required for structure and function. This gene encodes a protein which interacts with nebulin in skeletal muscle or nebulette in cardiac muscle and alpha-actinin. In addition, this gene product can interact with a protein with the I-band indicating it has a regulatory as well as structural function. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011]
MYPN Gene-Disease associations (from GenCC):
  • MYPN-related myopathy
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • cap myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • childhood-onset nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial isolated restrictive cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • dilated cardiomyopathy 1KK
    Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0033382177).
BP6
Variant 10-68148400-T-C is Benign according to our data. Variant chr10-68148400-T-C is described in ClinVar as Benign. ClinVar VariationId is 31793.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.321 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYPNNM_032578.4 linkc.1178T>C p.Val393Ala missense_variant Exon 5 of 20 ENST00000358913.10 NP_115967.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYPNENST00000358913.10 linkc.1178T>C p.Val393Ala missense_variant Exon 5 of 20 1 NM_032578.4 ENSP00000351790.5 Q86TC9-1

Frequencies

GnomAD3 genomes
AF:
0.104
AC:
15775
AN:
152070
Hom.:
2315
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.326
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0467
Gnomad ASJ
AF:
0.00951
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0274
Gnomad FIN
AF:
0.0140
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0158
Gnomad OTH
AF:
0.0894
GnomAD2 exomes
AF:
0.0390
AC:
9797
AN:
251430
AF XY:
0.0342
show subpopulations
Gnomad AFR exome
AF:
0.333
Gnomad AMR exome
AF:
0.0264
Gnomad ASJ exome
AF:
0.00963
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0127
Gnomad NFE exome
AF:
0.0159
Gnomad OTH exome
AF:
0.0316
GnomAD4 exome
AF:
0.0240
AC:
35104
AN:
1461730
Hom.:
2319
Cov.:
31
AF XY:
0.0237
AC XY:
17240
AN XY:
727166
show subpopulations
African (AFR)
AF:
0.336
AC:
11234
AN:
33456
American (AMR)
AF:
0.0283
AC:
1267
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00853
AC:
223
AN:
26134
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39700
South Asian (SAS)
AF:
0.0365
AC:
3148
AN:
86256
European-Finnish (FIN)
AF:
0.0128
AC:
684
AN:
53416
Middle Eastern (MID)
AF:
0.0569
AC:
328
AN:
5764
European-Non Finnish (NFE)
AF:
0.0142
AC:
15814
AN:
1111890
Other (OTH)
AF:
0.0398
AC:
2402
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
1667
3333
5000
6666
8333
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
724
1448
2172
2896
3620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.104
AC:
15823
AN:
152188
Hom.:
2326
Cov.:
32
AF XY:
0.101
AC XY:
7481
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.326
AC:
13514
AN:
41464
American (AMR)
AF:
0.0466
AC:
713
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00951
AC:
33
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.0276
AC:
133
AN:
4822
European-Finnish (FIN)
AF:
0.0140
AC:
149
AN:
10620
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0158
AC:
1074
AN:
68014
Other (OTH)
AF:
0.0885
AC:
187
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
584
1168
1753
2337
2921
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0462
Hom.:
2285
Bravo
AF:
0.116
TwinsUK
AF:
0.0138
AC:
51
ALSPAC
AF:
0.0140
AC:
54
ESP6500AA
AF:
0.332
AC:
1464
ESP6500EA
AF:
0.0147
AC:
126
ExAC
AF:
0.0452
AC:
5491
Asia WGS
AF:
0.0360
AC:
125
AN:
3478
EpiCase
AF:
0.0183
EpiControl
AF:
0.0164

ClinVar

Significance: Benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Dec 10, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jun 24, 2013
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

May 13, 2016
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Val393Ala in exon 6 of MYPN: This variant is not expected to have clinical sig nificance because it has been identified in 33.2% (1464/4406) of African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs11596653). -

not provided Benign:1Other:1
Apr 27, 2012
Leiden Muscular Dystrophy (MYPN)
Significance:not provided
Review Status:no classification provided
Collection Method:curation

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dilated cardiomyopathy 1KK Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jun 19, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
15
DANN
Benign
0.93
DEOGEN2
Benign
0.024
.;.;.;T;.
Eigen
Benign
-0.70
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.046
N
LIST_S2
Benign
0.046
T;T;.;T;T
MetaRNN
Benign
0.0033
T;T;T;T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-0.20
N;.;N;.;N
PhyloP100
0.42
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.090
N;N;N;.;N
REVEL
Benign
0.037
Sift
Benign
0.45
T;T;T;.;T
Sift4G
Benign
0.40
T;T;T;T;T
Polyphen
0.0
B;B;B;.;B
Vest4
0.049
MPC
0.16
ClinPred
0.0021
T
GERP RS
2.5
Varity_R
0.034
gMVP
0.16
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11596653; hg19: chr10-69908157; API